BTK and chronic myelogenous leukemia, BCR-ABL1 positive: Somatic gain-of-function mutations in BTK have also been identified in colorectal carcinoma [47], acute lymphoblastic leukemia (ALL) [48], and chronic myeloid leukemia (CML) [49].